Good Morning, Traders!…👋

U.S. stock futures edged higher on Tuesday, kicking off a holiday-shortened week marked by anticipation of the upcoming Federal Reserve minutes and continued uncertainty from President Trump’s policy overhaul.

Following Monday’s President’s Day closure, investors remain cautiously upbeat while debating the future path of interest rates. Over the long weekend, Fed officials underscored the need to maintain high rates to combat rising inflation, setting the stage for the release of January meeting minutes on Wednesday.

Eyes are particularly on Thursday’s releases from Alibaba, Walmart, and Dropbox, while Tuesday will bring quarterly reports from Devon Energy, Oxy, and Toll Brothers. Stay tuned as these developments continue to shape market sentimentmport prices and industrial production data set for release later in the session.

Happening Today

✓ 08:30 AM ET – NY Empire State Manufacturing Index (Feb)

✓ 10:20 AM ET – FOMC Member Daly Speaks

✓ 01:00 PM ET – Fed Vice Chair for Supervision Barr Speaks

✓ 04:00 PM ET – TIC Net Long-Term Transactions (Dec)

✓ 09:00 PM ET – U.S. President Trump Speaks

PREMARKET SNAPSHOT 📈

U.S. stock futures are slightly higher as investors anticipate Federal Reserve policy decisions and monitor ongoing U.S.-Russia discussions in Saudi Arabia.

SECTOR SNAPSHOT✨

Yesterday markets showed mixed performance, with Information Technology and Communication Services posting gains, while Energy and Financials saw slight increases. Consumer Staples, Health Care, and Industrials faced notable declines, dragging down overall sentiment. Real Estate and Utilities also slipped, reflecting cautious investor sentiment across defensive sectors.

PreMarket Unusual Volume Stocks

📈 Energy Focus Inc. (EFOI) is experiencing a substantial pre-market surge, with volume skyrocketing to 14.09 million shares compared to its average of just 8,370. The stock is currently trading at $2.17, marking a 68.22% increase. Such an unusual volume spike suggests significant investor interest, likely driven by news or a technical breakout.

📈 GlycoMimetics Inc. (GLYC) has seen a remarkable increase in pre-market trading activity, with 24.36 million shares exchanged—far exceeding its average volume of 955,490. The stock is currently priced at $0.40, up 38.97%, signaling strong momentum that could be linked to biotech sector news or positive company-specific catalysts.

📈 GCL Global Holdings Ltd. (GCL) is another notable pre-market mover, with trading volume reaching 3.14 million shares, significantly above its average of 125,890. The stock has surged 68.57% to $5.14, suggesting heightened speculative interest, possibly fueled by a recent corporate update or investor positioning ahead of earnings.

📈 Healthcare Triangle Inc. (HCTI) is seeing a considerable pre-market uptick, with 7.33 million shares traded, well above its average of 543,320. The stock is trading at $0.78, reflecting a 63.17% increase. The sudden volume spike may indicate growing attention from traders anticipating further upside.

📈 Innate Pharma ADR (IPHA) rounds out today's pre-market high-volume stocks, with 6.07 million shares traded against an average of 509,810. The stock has climbed 37.63% to $2.67, reflecting strong demand likely spurred by positive biotech sector sentiment or company-specific developments.

Premarket Picks

Digital Ally, Inc. (DGLY) surged by 14.08% in pre-market trading, with shares reaching $0.08. The rise comes after the company announced the successful closing of a $15.0 million underwritten public offering.

Innate Pharma S.A. (IPHA) saw a substantial 32.82% increase in its pre-market price, which climbed to $2.59. This surge followed the announcement that the U.S. FDA granted Breakthrough Therapy Designation to Lacutamab for treating relapsed or refractory Sézary Syndrome.

SRM Entertainment, Inc. (SRM) experienced a 41.98% jump in pre-market trading, bringing its price to $0.99. The increase is attributed to a lock-up agreement with Safety Shot, Inc., covering 2,347,142 shares of the company’s common stock.

GeneDx Holdings Corp. (WGS) rose by 28.03% in pre-market trading, with shares reaching $97.75. The boost followed the company’s announcement of strong financial results for Q4 and the full year of 2024, reporting $95.3 million in revenues for Q4.

Below is a complete list of hot stocks in pre-market today:

Top Upgrades:

1. Altice USA, Inc. (ATUS)

Analyst Firm: Raymond James
Upgraded: Market Perform to Outperform
Price Target: $3.50
Friday's Close: $2.82

Raymond James raised its rating on Altice USA to Outperform from Market Perform and set a price target of $3.50. The high estimate for Altice USA's stock price is $7.40, with a median target of $2.00, a low estimate of $1.00, and an average of $2.71. Altice USA, Inc. and its subsidiaries offer broadband and video services across the U.S., Canada, Puerto Rico, and the Virgin Islands.

2. Snowflake Inc. (SNOW)

Analyst Firm: Wolfe Research
Upgraded: Peer Perform to Outperform
Price Target: $235
Friday's Close: $187.60

Wolfe Research analyst Alex Zukin upgraded Snowflake to Outperform from Peer Perform, with a price target of $235. Analysts have set the high stock price estimate for Snowflake at $235.00, with a median target of $200.00, a low estimate of $115.00, and an average of $195.97. Snowflake Inc. provides a cloud-based data platform for organizations in the United States and around the world.

3. Tapestry, Inc. (TPR)

Analyst Firm: Redburn Atlantic
Upgraded: Neutral to Buy
Price Target: $110
Friday's Close: $87.70

Redburn Atlantic upgraded Tapestry to Buy from Neutral, with a price target of $110. The high estimate for Tapestry’s stock price is $104.00, with a median target of $92.50, a low estimate of $75.00, and an average of $90.94. Tapestry, Inc. offers luxury accessories and branded lifestyle products across North America, Greater China, and other international markets.

Happy investing,

Maeve Grace
Editor In Chief
Premium Stock Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.